Polyneuropathy, inflammatory demyelinating, chronic
MONDO:0100169Also known as: CIDP
53 clinical trials for this condition and its sub-types, 15 tagged with Polyneuropathy, inflammatory demyelinating, chronic itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control By invitation onlyThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for tough nerve disease: experimental drug riliprubart enters final testing
Disease control OngoingThis study tests a drug called riliprubart in 140 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hasn't improved with standard care. Participants receive either riliprubart or a placebo for up to 111 weeks. The main goal is to see if the drug reduces di…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC